ArticleKidney research and clinical practice2026
Transcriptional regulatory factors of the Aqp2 gene.
Article in Kidney research and clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption.The Journal of clinical investigation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Aquaporin-2 (AQP2), the water channel protein exclusively expressed in the kidney collecting duct, plays an essential role in water reabsorption and fluid homeostasis. Dysregulation of Aqp2 transcription and changes in protein abundance lead to water balance disorders such as nephrogenic diabetes insipidus or water overload states. Recent studies have revealed that Aqp2 transcription is highly selective, with only 35 of 3,659 genes exhibiting vasopressin-dependent regulation. Two enhancer elements within a CCCTC-binding factor-insulated topologically associating domain containing the Aqp2 gene control this precise regulation. Contrary to earlier assumptions, ChIP-seq analyses have demonstrated that cyclic adenosine monophosphate-responsive element binding protein (CREB) does not bind within 390 kb of the Aqp2 gene body. Instead, the extended transcription factor candidates, including GATA-binding protein 2 (GATA2), GATA3, and NFATc1, working cooperatively with Yes-associated protein (YAP), have been proposed as one of the key regulators of Aqp2 transcription. This review consolidates the current knowledge of Aqp2 gene regulation, focusing on recent transcriptional studies that have improved the understanding of AQP2 expression patterns. This review discusses the complexity of the Aqp2 gene regulation by integrating information from genome-wide analyses and mechanistic studies. Moreover, the findings provide important insights for translational research and represent significant progress in developing therapeutic strategies for water balance disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.